Also, the investigation of FGF21 levels in HT patients with known obesity, metabolic syndrome, cardiovascular disease, and obesity is necessary to clarify the effect of lower FGF21 on the incidence of the mentioned pathologies. The gene discussed is FGF21; the disease is Obesity.